To address these gaps, we conducted a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort to evaluate the associations of eleven cytokines and adipokines linked to inflammation or immune function (tumour necrosis factor [TNF]-α, interferon [IFN]-γ, interleukin [IL]-6, IL-8, IL-10, IL-13, IL-17D, IL-1RA, CRP, leptin, adiponectin) with breast cancer risk, overall and by menopausal status. The gene discussed is ADIPOQ; the disease is breast cancer.